Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC.TMCI · Entity 5943 | Chief Innovation Officer | August 09, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TREACE MEDICAL CONCEPTS, INC.
Report date August 09, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 679,863 |
Reported balance
After 2026-08-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-09 · Tax withholding · Disposed 9,814 · Balance 679,863 F1: Includes 463,167 restricted stock units. F2: Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 463,167 restricted stock units.
F2: Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2022 Filed Feb 10, 2022 22:08 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 3,873 | $20.16 | $78,081.62 |
DisclosureSEC source: 0001567619-22-003261 · doc1.xml · nonDerivative · entry 4 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.27 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2022 Filed Feb 10, 2022 22:08 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 3,873 | $1.05 | $4,066.65 |
DisclosureSEC source: 0001567619-22-003261 · doc1.xml · nonDerivative · entry 3 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:08 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,127 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001567619-22-003261 · doc1.xml · derivative · entry 5 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,022 Underlying: Common Stock · 21,127 shares Expires 2028-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:08 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 21,127 | $20.02 | $422,888.60 |
DisclosureSEC source: 0001567619-22-003261 · doc1.xml · nonDerivative · entry 2 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.10 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:08 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 21,127 | $1.05 | $22,183.35 |
DisclosureSEC source: 0001567619-22-003261 · doc1.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,414 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · derivative · entry 10 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,149 Underlying: Common Stock · 6,414 shares Expires 2028-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 23, 2022. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,424 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · derivative · entry 9 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,820 Underlying: Common Stock · 2,424 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 22, 2023. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 8,838 | $20.12 | $177,846.19 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · nonDerivative · entry 6 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.34 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 6,414 | $1.05 | $6,734.70 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · nonDerivative · entry 5 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 2,424 | $1.57 | $3,805.68 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · nonDerivative · entry 4 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,631 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · derivative · entry 8 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,244 Underlying: Common Stock · 30,631 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 22, 2023. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,231 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · derivative · entry 7 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,993 Underlying: Common Stock · 8,231 shares Expires 2029-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 38,862 | $20.16 | $783,531.76 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · nonDerivative · entry 3 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.62 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 30,631 | $1.57 | $48,090.67 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · nonDerivative · entry 2 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:01 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 8,231 | $1.57 | $12,922.67 |
DisclosureSEC source: 0001567619-22-001142 · doc1.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · derivative · entry 9 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,224 Underlying: Common Stock · 800 shares Expires 2029-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 800 | $20.02 | $16,018.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · nonDerivative · entry 6 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 800 | $1.57 | $1,256.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · nonDerivative · entry 5 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · derivative · entry 8 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,024 Underlying: Common Stock · 500 shares Expires 2029-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 500 | $20.00 | $10,000.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · nonDerivative · entry 4 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 500 | $1.57 | $785.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · nonDerivative · entry 3 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · derivative · entry 7 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,524 Underlying: Common Stock · 1,000 shares Expires 2029-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 1,000 | $20.02 | $20,021.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · nonDerivative · entry 2 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.06 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:57 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 1,000 | $1.57 | $1,570.00 |
DisclosureSEC source: 0001567619-22-000672 · doc1.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 00:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001567619-21-020114 · doc1.xml · derivative · entry 4 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,524 Underlying: Common Stock · 25,000 shares Expires 2029-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 00:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 440 | $22.20 | $9,767.16 |
DisclosureSEC source: 0001567619-21-020114 · doc1.xml · nonDerivative · entry 3 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.15 to $22.26 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 00:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 24,560 | $21.53 | $528,663.82 |
DisclosureSEC source: 0001567619-21-020114 · doc1.xml · nonDerivative · entry 2 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.14 to $22.13 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 13, 2021 00:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Exercise / conversionCommon Stock | 25,000 | $1.57 | $39,250.00 |
DisclosureSEC source: 0001567619-21-020114 · doc1.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · SVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 22, 2021 Filed Apr 27, 2021 00:59 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 66,875 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017032 · doc4.xml · derivative · entry 1 Scanlan Sean F. · CIK 0001856371 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,875 Underlying: Common Stock · 66,875 shares Expires 2031-04-22 F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025; subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.